Press Releases

Modern Healthcare Recognizes IVX Health in its 2022 Best Places to Work in Healthcare List

For the fourth consecutive year, IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare in 2022. This annual program identifies and honors 150 outstanding companies and organizations in the healthcare industry nationwide, and IVX Health was ranked No. 20 overall in one of its two category designations. “At many of the organizations highlighted, it starts with instilling a sense of balance—and not just the general work-life balance employees crave, but the balance that comes from understanding their...

Komodo Health Appoints Lauren Stahl as Head of Sales

Komodo Health announced that Lauren Stahl has been appointed as the company’s vice president and head of sales, effective immediately. In this role, Stahl’s responsibilities include sales team leadership across Komodo’s entire portfolio of customers, overseeing operational strategy to drive business efficiencies, and year-over-year growth and market expansion. As head of sales, Stahl will oversee Komodo Heath’s entire sales organization, with responsibilities for driving business and revenue growth as Komodo scales its offerings and footprint across more than a dozen market segments. “Lauren has demonstrated an exceptional...

Augmedix Launches New Service, Augmedix Prep, to Significantly Reduce Physician Chart Prep Burden

Augmedix, a provider of automated medical documentation solutions, has announced the launch of Augmedix Prep, a new service that significantly reduces the burden on medical staff from preparing charts prior to a patient visit. The new service features specialized technology that prepares a patient note structure and content for the physician based on the unique visit type and the patient’s previous medical records. Typically, physicians need to do this before they see a patient, but with Augmedix Prep, all the provider needs to do is review...

Augmedix Reports Second Quarter 2022 Financial Results

On August 8, 2022, Augmedix reported its financial results for the three-month period that ended on June 30, 2022. Manny Krakaris, chief executive officer of Augmedix, noted that “we continued to see good momentum and are pleased with our strong start to 2022. We remain focused on our path to profitability as we drive enterprise customer expansion, make good progress on our automation and new product development, and scale our business model… As physician retention, burnout, and staffing shortages continue to impact healthcare organizations, our...

Augmedix Announces Expanded Partnership with Adventist Health

Augmedix has announced a groundbreaking partnership with Adventist Health. The data-driven partnership aims to utilize Adventist’s experience as a nonprofit health system integrated into more than 80 communities in the western United States. The partnership was reached as a piece of a scalable plan to aid physicians who are burdened by time-consuming administrative tasks. The partnership will help those physicians by providing automated solutions that can alleviate a part of the physician’s workload. The AI technology will cover issues like medical documentation and live clinical services. Manny...

C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research

Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, have announced a partnership that uses synthetic data to help researchers more easily develop drugs to treat rare diseases. Replica Analytics will help generate synthetic datasets across rare and orphan indications in which patient-level datasets are often quite small, which heightens considerations regarding data privacy and accessibility. Together with real data, these synthetic data will help maximize the utility of C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), which provides a standardized and centralized infrastructure to...

Merck Announces the Launch of the Merck Digital Sciences Studio to Help Healthcare Startups Quickly Bring their Innovations to Market

Merck, known as MSD outside the U.S. and Canada, has announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct investment, access to Azure Cloud computing, and opportunities to pilot their technologies in collaboration with discovery and clinical scientists at Merck. The MDSS is a collaboration between Merck and the New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology corporation. McKesson Ventures is one...

McKesson Ventures Takes the ParityPledge to Commit to Increasing Representation for Women and People of Color

McKesson Ventures has signed the Parity.org ParityPledge® in Support of People of Color and in Support of Women. The ParityPledge simply asks that companies commit to interview and consider at least one qualified woman and person of color for every open role, VP and above, including the C-suite and the board of directors. Parity.org is a 501(c)(3) not-for-profit organization focused on bringing gender and racial equality to the highest levels of business, calling for “Equal Representation. Now.” “We are proud to be involved in the ParityPledge,”...

OncoHealth Secures Strategic Investments from Arsenal Capital Partners & McKesson Corporation

OncoHealth announced today that Arsenal Capital Partners and McKesson Corporation have strategically invested in the company. The funding, which gives Arsenal a majority ownership stake in OncoHealth, will help the company continue developing its oncology-focused digital health platform. John DiGiovanni, an Investment Partner at Arsenal said of the investment, “Arsenal is focused on helping to build businesses that are tackling healthcare’s most pressing challenges.” He continued, “…OncoHealth is removing administrative burdens for health plans and providers, facilitating stakeholder alignment, and improving the patient experience.” Brian Tyler, CEO...

Reimagine Care and University of Colorado Anschutz Medical Campus Collaborate to Provide Home-Centered Care to Bone Marrow Transplant Patients

Reimagine Care, a provider of technology-enabled services that support oncologists in delivering high-quality, home-centered, value-based cancer care, has collaborated with the University of Colorado Anschutz Medical Campus (CU Anschutz) to deliver care to bone marrow transplant patients. The collaboration will leverage specialized clinical technology, advanced remote patient monitoring (RPM), and Reimagine Care’s Virtual Care Center to detect infections earlier and begin life-saving treatments faster to improve outcomes and enhance patient and caregiver experience. Bone marrow transplant patients are especially vulnerable post-transplant because their immune systems are...